JAMIE MARFURT: Open Payments
NPI 1265919369 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 20 payments from 14 companies in 2025. Trend: 2023 $2,119 · 2024 $2,829 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 5 | $253 |
| ABBVIE INC. | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Exact Sciences Corporation | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: MYRISK, Cologuard Collection Kit, Auvelity, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, OTEZLA, EVENITY.
Industry payments across NY — which companies pay providers there.
